Systematic Reviews
Copyright ©The Author(s) 2024.
World J Gastroenterol. Mar 7, 2024; 30(9): 1213-1223
Published online Mar 7, 2024. doi: 10.3748/wjg.v30.i9.1213
Figure 2
Figure 2 Vonoprazan triple therapy and tegoprazan triple therapy vs conventional proton pump inhibitor triple therapy - randomized controlled studies. A: Vonoprazan triple therapy; B: Tegoprazan triple therapy. RR: Risk ratio; CI: Confidence interval.